YZi Labs—an investment entity supported by Binance founder Changpeng Zhao—has publicly criticized CEA Industries (NASDAQ: BNC) for implementing what it calls “anti-shareholder” strategies aimed at solidifying the existing leadership’s position. This rebuke highlights a growing rift in a relationship that appeared promising just half a year ago.
— YZi Labs (@yzilabs) January 7, 2026
The controversy unfolded in a statement shared via X on Wednesday, where YZi Labs, a significant stakeholder in the BNB-focused treasury company, contended that CEA’s new shareholder rights plan—often referred to as a poison pill—and revisions to its corporate bylaws are intended to hinder investors from initiating changes through written agreements.
This comes after an initial collaboration that seemed mutually beneficial, but has now devolved into open hostility.
The discord intensified last month when YZi Labs submitted regulatory documents outlining an assertive push to reshape CEA’s governance.
Their proposals included enlarging the board, reversing recent bylaw modifications, and appointing their preferred candidates via a shareholder consent mechanism.
Subsequently, YZi Labs sought approval to assemble a collaborative investor alliance to bolster its ownership in the firm.
YZi Labs has pointed to CEA’s lackluster results following a $500 million private investment round completed in July.
Despite the substantial influx of capital, the company has allegedly strayed from its primary focus, even as its key holding, the BNB cryptocurrency, experienced steady appreciation.
This mismatch, according to YZi, has eroded investor confidence.
In retaliation to YZi’s maneuvers, CEA’s directors introduced a temporary shareholder rights agreement and updated their bylaws.
A poison pill serves as a protective strategy for corporations facing potential unwanted acquisitions, rendering such efforts costlier or less feasible by flooding the market with discounted shares.
Specifically, CEA’s plan activates if an entity or coalition amasses 15% or more of the company’s stock without prior board consent, enabling remaining shareholders to acquire extra shares at half price, thereby diluting the aggressor’s influence and inflating takeover expenses.
YZi Labs voiced strong dissatisfaction in its latest communication, labeling these steps as detrimental to investor rights and deliberately obstructive to their consent campaign.
They further highlighted remarks from CEA’s chief executive, David Namdar, suggesting a possible shift toward alternative digital assets like Solana, which has alarmed backers committed to the BNB-centric approach.
Additionally, YZi alleged that CEA is postponing its yearly shareholder gathering and cautioned against any underhanded tactics in managing the event or board selections.
Ella Zhang, YZi Labs’ head, conveyed in a statement to media outlets that the firm remains dedicated to productive discussions, safeguarding investor rights, and upholding the strength and worth of the BNB network.
This clash stands in stark opposition to the enthusiasm surrounding CEA’s earlier transition from e-cigarette production, which sparked a 600% spike in its share value after the major funding injection from 10X Capital and YZi Labs.
As of Tuesday’s market close, CEA Industries (ticker: BNC) rose 1.56% to $6.51.
However, over the prior six months, the stock has declined considerably by 36.67%, contrasting sharply with BNB‘s approximate 38% increase during the same timeframe, per market data.
As this boardroom battle unfolds, it underscores ongoing broader tensions in the evolving crypto treasury sector, where strategic alignments can, in some instances, turn adversarial.